Growth hormone axis
Ipamorelin
- 10 mg
Custom strengths on request
Not FDA-approved. Not on FDA's 503A category lists (May 14, 2026). Source, May 14, 2026
At a glance
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
0.03 mg/kg per dose, intravenous infusion (postoperative ileus trial)
Human study
- Frequency
- twice daily
- Route
- intravenous infusion
- Course
- postoperative day 1 to 7 or hospital discharge
Both human studies used intravenous dosing only; no subcutaneous human dosing is established, so do not extrapolate these figures to subcutaneous use.
Get a quote
Custom strengths on request. Prices are quoted per clinic.